rs510769
| Orientation | minus |
| Stabilized | minus |
| Make rs510769(A;A) |
| Make rs510769(A;G) |
| Make rs510769(G;G) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 6 |
| Position | 154040884 |
| Gene | OPRM1 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs510769 |
| dbSNP (classic) | rs510769 |
| ClinGen | rs510769 |
| ebi | rs510769 |
| HLI | rs510769 |
| Exac | rs510769 |
| Gnomad | rs510769 |
| Varsome | rs510769 |
| LitVar | rs510769 |
| Map | rs510769 |
| PheGenI | rs510769 |
| Biobank | rs510769 |
| 1000 genomes | rs510769 |
| hgdp | rs510769 |
| ensembl | rs510769 |
| geneview | rs510769 |
| scholar | rs510769 |
| rs510769 | |
| pharmgkb | rs510769 |
| gwascentral | rs510769 |
| openSNP | rs510769 |
| 23andMe | rs510769 |
| SNPshot | rs510769 |
| SNPdbe | rs510769 |
| MSV3d | rs510769 |
| GWAS Ctlg | rs510769 |
| GMAF | 0.2185 |
| Max Magnitude | 0 |
| ? | (A;A) (A;G) (G;G) | 28 |
|---|---|---|
|
| ||
[PMID 18518925
] Genetic susceptibility to heroin addiction: a candidate gene association study
[PMID 12771227] MALDI mass spectrometry analysis of single nucleotide polymorphisms by photocleavage and charge-tagging.
[PMID 14656974] Clone-based systematic haplotyping (CSH): a procedure for physical haplotyping of whole genomes.
[PMID 16887046] The mu-opioid receptor gene and smoking initiation and nicotine dependence.
[PMID 17135278] Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs.
[PMID 18783506] Association of a single nucleotide polymorphism in neuronal acetylcholine receptor subunit alpha 5 (CHRNA5) with smoking status and with 'pleasurable buzz' during early experimentation with smoking.
[PMID 19053977] OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach.
[PMID 19500151] Heroin addiction in African Americans: a hypothesis-driven association study.
[PMID 20100356] PCA-based bootstrap confidence interval tests for gene-disease association involving multiple SNPs.
[PMID 21029375] OPRM1 gene variants modulate amphetamine-induced euphoria in humans.
[PMID 22406240] Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients.
